UKpolicy

Market Access

drug pricing in the UK, pills overlain on map

Request to look further into NICE non-submissions in the fut...

Leela Barham looks at the discussion on non-submissions to the HTA body NICE, informed by the latest metrics for VPAG.

News

Inside of intestine at bacterial level - concept of microbiome meds

MHRA clarifies UK position on microbiome-based medicines

The MHRA has published its position paper clarifying how microbiome-based medicines can be made available for patients in the UK.

Patients

Innovation can transform NHS care, but scaling is the missin...

Innovation is already improving care across the NHS, but we are not yet consistently delivering at scale for the benefit of patients

News

England close to eliminating hep C thanks to treatment drive

England is on track to be one of the first countries in the world to eliminate hepatitis C, thanks to a national diagnosis and treatment programme.

Market Access

Three separate injections - blue, red, and yellow - take off against black background

Why global pharmaceutical reforms are quietly redirecting ra...

Publication of the 2026 Pharma Package by the Council of the EU represents the most significant reform of EU pharmaceutical legislation in over 20 yrs

News

Cytokinetics' cardiomyopathy drug cleared for NHS use

Cytokinetics gets simultaneous MHRA and NICE approvals for hypertrophic cardiomyopathy (HCM) therapy Myqorzo.

Request to look further into NICE non-submissions in the fut...

MHRA clarifies UK position on microbiome-based medicines

Innovation can transform NHS care, but scaling is the missin...

England close to eliminating hep C thanks to treatment drive

Why global pharmaceutical reforms are quietly redirecting ra...

Cytokinetics' cardiomyopathy drug cleared for NHS use

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

UKpolicy

Editor's Picks